![Hans-Peter Hartung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans-Peter Hartung
Chairman at Neuroscience Center, Inc.
Network origin in Hans-Peter Hartung first degree
Entity | Entity type | Industry | |
---|---|---|---|
Opexa Therapeutics, Inc.
![]() Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX.
17
| Extinct | Pharmaceuticals: Major | 17 |
Heinrich-Heine-Universität Düsseldorf
11
| College/University | Other Consumer Services | 11 |
Neuroscience Center, Inc.
![]() Neuroscience Center, Inc. Hospital/Nursing ManagementHealth Services Neuroscience Center, Inc. provides hospital services.
2
| Private Company | Hospital/Nursing Management | 2 |
Multiple Sclerosis International Federation
![]() Multiple Sclerosis International Federation Miscellaneous Commercial ServicesCommercial Services The Multiple Sclerosis International Federation is an international network of over 90 MS organizations. The non-profit company is based in London, UK. The organization provides information on MS in English, Arabic, and Spanish.
2
| Non-Profit Organization | Miscellaneous Commercial Services | 2 |
European Committee for Treatment & Research in Multiple
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hans-Peter Hartung via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal Comptroller/Controller/Auditor | |
Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
University of Notre Dame | College/University | Undergraduate Degree Graduate Degree | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
evocatal GmbH
![]() evocatal GmbH Chemicals: Major DiversifiedProcess Industries evocatal GmbH operates as a biotechnology company. The firm specializes in the development and production of tailor-made biocatalysts and fine chemicals. Its products include carbohydrates enzymes, fine chemicals, and evoglow. The company was founded by Thorsten Eggert in August 2006 and is headquartered in Monheim am Rhein, Germany. | Chemicals: Major Diversified | Corporate Officer/Principal Sales & Marketing | |
Baylor College of Medicine | College/University | Corporate Officer/Principal Undergraduate Degree | |
University of Toronto | College/University | Doctorate Degree Undergraduate Degree | |
Henkel Management AG
![]() Henkel Management AG Miscellaneous Commercial ServicesCommercial Services Part of Henkel AG & Co. KGaA, Henkel Management AG is a German company that provides management services. The company is based in Dusseldorf, Germany. The company was founded in 2008. Carsten Knobel has been the CEO of the company since 1995. | Miscellaneous Commercial Services | Chairman | |
Antiinfectives Intelligence GmbH | Chief Executive Officer | ||
Gesellschaft für klinisch-mikrobiologische Forschung | Director/Board Member | ||
University of Münster | College/University | Undergraduate Degree | |
Ruhr-Universität Bochum | College/University | Graduate Degree | |
Thermosome GmbH
![]() Thermosome GmbH Pharmaceuticals: MajorHealth Technology Thermosome GmbH develops novel drugs for solid tumors. Its technology is used for delivery of various active pharmaceutical ingredients with its application in localized diseases. The company was founded by Lars Lindner, Martin Hossan and Hansjoerg Eibl and is headquartered in Planegg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
High-Tech Gründerfonds Management GmbH
![]() High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor | |
Black Horse Properties GmbH
![]() Black Horse Properties GmbH Real Estate DevelopmentFinance Black Horse Properties GmbH is a German company that buys and sells land, buildings, and apartments. The private company is based in Dusseldorf, Germany. The CEOs are Patrick Schwarz-Schütte, Torsten Schreiber, Michaela Steimel. The company was founded in 2014. | Real Estate Development | Chief Executive Officer | |
Booz Allen Hamilton, Inc.
![]() Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | Engineering & Construction | Corporate Officer/Principal | |
Black Horse Investments GmbH
![]() Black Horse Investments GmbH Financial ConglomeratesFinance Black Horse Investments GmbH provides investment services. The firm's investment operations focus on pharmaceutical businesses and property development activities. Its focus areas encompass asset management, project management, and business development and financing. The company is headquartered in Duesseldorf, Germany. | Financial Conglomerates | Chief Executive Officer | |
Jost Henkel Foundation | Director/Board Member | ||
Rotary Düsseldorf | Corporate Officer/Principal | ||
Cognis BV
![]() Cognis BV Chemicals: SpecialtyProcess Industries Cognis BV manufactures chemicals based natural oils and animal fats. It develops products and solutions for personal care, home care, and nutrition products for industrial markets. The company was founded in December 1999 is headquartered in Roermond, the Netherlands. | Chemicals: Specialty | Director/Board Member | |
Rawabi Holding Co. Ltd.
![]() Rawabi Holding Co. Ltd. Oilfield Services/EquipmentIndustrial Services Rawabi Holding Co. Ltd. operates as a holding company with interests in providing oilfield services. It caters its services to the oil, gas and petrochemicals; engineering and construction, power, telecom, and information technology, corrosion and industrial services. The firm also offers contracting and industrial services throughout the Middle East. The company is founded in 1975 and is headquartered in Al Khobar, Saudi Arabia. | Oilfield Services/Equipment | Chairman | |
GULF UNION ALAHLIA COOPERATIVE INSURANCE COMPANY | Multi-Line Insurance | Chairman | |
The Park Foundation, Inc. | Financial Conglomerates | Director/Board Member | |
DEUTSCHLAND RUNDET AUF Gemeinnützige Stiftungs-GmbH
![]() DEUTSCHLAND RUNDET AUF Gemeinnützige Stiftungs-GmbH Investment Trusts/Mutual FundsMiscellaneous DEUTSCHLAND RUNDET AUF Gemeinnützige Stiftungs-GmbH engages in the collection and management of donations in the form of cash for the financial support of charitable and non-profit projects. The company was founded by Christian Vater on November 30, 2009 and is headquartered in Berlin, Germany. | Investment Trusts/Mutual Funds | Director/Board Member | |
Düsseldorf Business School | College/University | Director/Board Member | |
Stifterverband für die Deutsche Wissenschaft eV | Corporate Officer/Principal | ||
BAYER AG | Pharmaceuticals: Major | Director/Board Member | |
Stiftung Schloss und Park Benrath | Director/Board Member | ||
HENKEL AG & CO. KGAA | Household/Personal Care | Chairman | |
University of Bonn | College/University | Undergraduate Degree | |
Heraeus Holding GmbH
![]() Heraeus Holding GmbH Wholesale DistributorsDistribution Services Heraeus Holding GmbH operates as a technology company. It focuses on the environmental, energy, electronics, health, mobility and industrial applications sectors. The company was founded by Willhelm Carl Heraeus in 1851 and is headquartered in Hanau, Germany. | Wholesale Distributors | Director/Board Member | |
Fritz Henkel Foundation | Director/Board Member | ||
University of Hamburg | College/University | Undergraduate Degree | |
Konrad Henkel Foundation | Director/Board Member | ||
Promentis Pharmaceuticals, Inc.
![]() Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI. | Pharmaceuticals: Major | Director/Board Member | |
UCB | Pharmaceuticals: Major | Director/Board Member | |
GeneExcel LLC | Director/Board Member | ||
TVM Capital GmbH
![]() TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Chairman |
Statistics
International
Germany | 28 |
United States | 17 |
Netherlands | 3 |
Saudi Arabia | 3 |
Canada | 2 |
Sectoral
Health Technology | 13 |
Consumer Services | 10 |
Finance | 9 |
Commercial Services | 4 |
Process Industries | 3 |
Operational
Director/Board Member | 171 |
Corporate Officer/Principal | 49 |
Chairman | 39 |
Independent Dir/Board Member | 35 |
Undergraduate Degree | 27 |
Most connected contacts
Insiders | |
---|---|
Luc Marengère | 31 |
Hubert Birner | 27 |
Abdul Aziz Al-Turki | 23 |
Timothy Barabe | 21 |
Gail Maderis | 20 |
Stephen Aselage | 20 |
Simone Bagel-Trah | 18 |
Michelle Griffin | 18 |
Detlev Riesner | 16 |
Michael Richman | 16 |
John Dunn | 15 |
Neil Warma | 15 |
Scott B. Seaman | 12 |
Jason Amello | 11 |
Garrett Herman | 10 |
- Stock Market
- Insiders
- Hans-Peter Hartung
- Company connections